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通过对 CS 的游离氨基进行巯基化而制得 TCS，但是现有的方法效率不高。
本论文对合成方法进行改进，大大提高了反应效率，使巯基结合率从 231.51 ± 




本论文选用另一种生物材料海藻酸钠(Sodium alginate, SA)与 CS/TCS 通过离
子交联法来制备纳米粒，过程简便、温和，无需使用有机溶剂，后处理简单。对
纳米粒进行处方优化，并比较 CS/TCS-SA 纳米粒在粒径、ζ电位、形态、黏附
性及药物释放性的差异，证实 TCS-SA 纳米粒各方面性能均优于 CS-SA 纳米粒。 
3.FITC 荧光分析方法的建立 
本论文对 FITC 的荧光分析方法进行了专属性、线性、精密度和加样回收率



















通过对比 FITC 溶液，包载 FITC 的 CS/TCS-SA 纳米粒的在体角膜透过性实
验，进一步确证纳米粒能增加 FITC 的角膜透过量，并且 TCS-SA 纳米粒的药物
角膜透过率比 CS-SA 纳米粒高得多，显示了 TCS-SA 纳米粒眼部传递系统的优
越性。 
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Abstract 
Nowadays, eye drops are widely used in ocular disease, but the short residence 
time and low effective concentration have seriously restricted the therapeutic effect. 
Consequently, the research and development of new ophthalmic preparations which 
are both high bioavailability and convenient to use is more and more important. Study 
found that Chitosan (CS) after being thiolated to thiolated chitosan (TCS), which 
became another novel high polymer mucoadhesive Materials – Thiomers or Thiolated 
polymers, the water solubility and mucoadhesive ability of TCS are much better than 
CS, besides, TCS displays gelling properties in situ at physiological pH, all these 
properties are beneficial to the development of ophthalmic preparation. Nanoparticles 
for its solubility, control release ability and low eye injure, has an extensive applied 
foreground as a ocular drug delivery system. The study was to prepare and optimize 
CS/TCS nanoparticles for ocular drug delivery, and evaluate the properties of NPs, 
cell uptake studies and in vivo studies were carried out, all these provided theoretical 
bases for the further research of the material and ophthalmic mucoadhesive 
preparation. The following parts are included in this paper: 
1. The improvement of the synthesis of TCS and evaluation 
To thiolated the primary amino groups of CS, we got TCS, but the efficiency was 
low. In this research work, the synthesis route was improved, and we obtained much 
higher thiol group immobilization in the polymer, from 231.51 ± 15.52 to 1411.01 ± 
4.02 μmol/g. TCS characteristics were determined using Fourier transform infrared 
spectroscopy, the degree of thiol immobilized was measured by Ellman’s reagent and 
the cytocompatibility with HCE (human corneal epithelium) cells. 
2. Preparation and Characterization of CS/TCS-SA NPs 
The study used another biological material – Sodium alginate (SA) to prepare NPs 
with CS/TCS by a modified ionic gelation method which was convenient, gentle, 
non-organic solvent, easy after treatment. The study also optimized the preparation, 
and compared the differents of CS/TCS-SA NPs in size, zeta potential, morphology, 
mucoadhesive properties and drug release, all these came out that TCS-SA NPs was 
much better than CS-SA NPs for ocular treatment. 















The study determined the specificity, linearity, accuracy and plus sample recovery, 
to develop a sensitive, efficient, accurate, convenient method for FITC. 
4. In vitro cell uptak studies of FITC loaded CS/TCS-SA NPs  
This may be further confirmation from the cell level that TCS-SA NPs are more 
effective as a potential system for ocular drug delivery, compared with CS-SA NPs. 
5.In vivo studies 
After comparing in vivo corneal permeation ability of FITC solution and 
FITC-loaded CS/TCS-SA NPs, we further confirmed that NPs can increase the 
permeation of FITC, and, TCS-SA NPs exhibited much better permeation ability than 
CS-SA NPs, which was more effective as a potential system for ocular drug delivery. 
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图 1.1 眼睛的解剖结构 




























图 1.2 滴眼液给药后的吸收途径 








































































Degree papers are in the “Xiamen University Electronic Theses and Dissertations Database”. Full
texts are available in the following ways: 
1. If your library is a CALIS member libraries, please log on http://etd.calis.edu.cn/ and submit
requests online, or consult the interlibrary loan department in your library. 
2. For users of non-CALIS member libraries, please mail to etd@xmu.edu.cn for delivery details.
厦
门
大
学
博
硕
士
论
文
摘
要
库
